EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).

September 29, 2020

VANCOUVER, BRITISH COLUMBIA, September 29, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (OTCQB:EXM…, (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is pleased to announce its membership to The Portuguese Association ...

EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities

September 08, 2020

VANCOUVER, BRITISH COLUMBIA, September 8th, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is pleased to announce its success in securing COVID-19 R&D-focused grant ...

EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic

August 25, 2020

VANCOUVER, BRITISH COLUMBIA, August 25th, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-science company specializing in the production of unique cannabinoid formulations, is pleased to announce the advancement of its R&D operations at ...

EXMceuticals Inc. Announces Shares for Debt Settlement

August 21, 2020

VANCOUVER, BRITISH COLUMBIA, August 21, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company”), announces that it has settled $1,378,241 of debt with creditors by issuing 4,139,161 common shares of the Company at deemed prices of $0.275, $0.30, $0.32, ...

EXMceuticals Inc. Announces Loan Settlement and Share Issuance

July 28, 2020

VANCOUVER, BRITISH COLUMBIA, July 28, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”) is pleased to announce that further to its news release dated July 22, 2020, pursuant to certain loan agreements previously entered into between ...

EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet

July 22, 2020

VANCOUVER, BRITISH COLUMBIA, July 22nd, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM") is pleased to announce that it has completed the sale of 5,180,000 units on a private placement basis at a price of $0.20 ...

EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate

June 10, 2020

VANCOUVER, BRITISH COLUMBIA, June 11, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), is pleased to announce that it has entered into a letter of intent ("LOI") with Econnabis SAS, an operating subsidiary of Plena Global ...

EXMceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery

May 07, 2020

VANCOUVER, BRITISH COLUMBIA, May 7th, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging producer of refined cannabis ingredients serving the pharmaceutical, medical, nutraceutical, and cosmetic industries, has secured supply agreements-in-principle of pharmaceutical/medical grade cannabis ...

EXMceuticals Inc. provides an update on operations and announces first closing of loan agreement

March 25, 2020

VANCOUVER, BRITISH COLUMBIA, March 25, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), a producer of refined cannabis ingredients for the pharmaceutical, medical, nutraceutical, and cosmetic industries, provides an update on our operations, the first closing ...

EXMceuticals Inc. provides an update on activities and announces a new Board Member and Corporate Secretary

March 02, 2020

VANCOUVER, BRITISH COLUMBIA, March 03, 2020 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to give a brief update ...